AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q4 2020 Results - Earnings Call Transcript
Aquestive Therapeutics, Inc. (AQST) Q4 2020 Earnings Conference Call March 10, 2021 08:00 ET Company Participants Stephanie Carrington - Investor Relations Keith Kendall - President and Chief Executive Officer Ernie Toth - Interim Chief Financial Officer Daniel Barber - Senior Vice President and Chief Operating Officer Conference Call Participants Gary Nachman - BMO Capital Markets Randall Stanicky - RBC Capital Markets Shveta Dighe - Wedbush Securities Jason Butler - JMP Securities Thomas Flaten - Lake Street Capital Markets Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Fourth Quarter 2020 Aquestive Therapeutics Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms. Stephanie Carrington. Ma’am, please go ahead. Stephanie Carrington Thank you, operator. Good morning and welcome to today’s call. On today’s call, I am joined by Keith Kendall, President and Chief Executive Officer and Ernie
For further details see:
Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q4 2020 Results - Earnings Call Transcript